Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
01/2000
01/12/2000EP0970103A1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain
01/11/2000US6013454 Kinesin-like motor protein
01/06/2000WO2000000507A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon
01/06/2000WO2000000468A1 Thyroid hormone analogues and methods for their preparation
01/06/2000WO2000000201A1 BICYCLIC sPLA2 INHIBITORS
01/06/2000CA2335448A1 Bicyclic spla2 inhibitors
01/06/2000CA2331388A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon
01/05/2000EP0968717A1 Galenic formulatin for reducing effects induced during or after menopause and method of treatment using same
01/05/2000EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
01/05/2000CN1240349A Stable glassy state powder formulations
01/04/2000US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives
12/1999
12/29/1999WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
12/29/1999EP0966299A2 Novel pharmaceutical compositions
12/29/1999CN1239967A 8(9)-dehydroestradiol derivatives
12/29/1999CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/28/1999US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia
12/23/1999WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065893A1 Novel benzopyran or thiobenzopyran derivatives
12/23/1999WO1999065489A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065482A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/23/1999CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999CA2335295A1 Methods for increasing levels of acetylcholine
12/23/1999CA2335078A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999CA2334634A1 Novel benzopyran or thiobenzopyran derivatives
12/22/1999EP0964852A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
12/22/1999EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/21/1999US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods
12/21/1999US6004944 Protein delivery by secretory gland expression
12/21/1999US6004938 Inositolglycans having insulin-like action
12/21/1999US6004931 Method for inhibiting growth hormone action
12/16/1999WO1999064615A1 Formulations for electroporation
12/16/1999WO1999064598A2 Novel insulin analogs with enhanced zinc binding
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064393A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999DE19826213A1 Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New antiestrogens, processes for their preparation and their pharmaceutical use
12/16/1999CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334780A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999CA2330211A1 Formulations for electroporation
12/15/1999CN1238781A Heptapeptide oxytocin analofues
12/14/1999CA2172137C Surface loop structural analogues of fibroblast growth factors
12/14/1999CA2030810C Grf analogs viia
12/09/1999WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062562A1 Prosthetic implant and methods of use for therapeutic gene expression
12/09/1999DE19825447A1 Neue Insulinanaloga mit erhöhter Zinkbildung New insulin analogues with increased zinc Education
12/09/1999CA2330172A1 Prosthetic implant and methods of use for therapeutic gene expression
12/08/1999EP0961794A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
12/08/1999CN1237905A Use of sibutramine analogues to prevent development of diabetes
12/07/1999US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/07/1999US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999US5998377 Administration of lh-rh antagonist cetrorelix in combination with at least one .alpha.-reductase inhibitor; without the side effects associated with testosterone levels being in a castration range.
12/07/1999US5997897 Process for the production of a transdermal therapeutic system comprising the active substance 17-β-estradiol (anhydrous)
12/07/1999CA2180717C Use of phosphorus derivatives of alkaloids for treating endocrinopathies
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999CA2329072A1 Human transmembrane proteins
12/01/1999EP0960105A1 Benzofurazan compounds which enhance ampa receptor activity
12/01/1999EP0833646B1 Multi-tyrosinated somatostatin analogs
11/1999
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994411 Formulated product for embryonic retardation or discordance
11/30/1999US5994384 Hypersensitization of adrenergic receptors
11/30/1999US5994370 Indene compounds having activity as SERMS
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993783 Aerosols
11/30/1999CA2030795C Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
11/25/1999WO1999059969A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059581A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2331318A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999CA2329530A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/24/1999EP0957921A1 METHOD OF PREVENTING NEURODEGENERATION AND COGNITIVE DYSFUNCTION USING 17$g(a)-DIHYDROEQUILENIN
11/24/1999EP0730470A4 Improved interferon polymer conjugates
11/24/1999CN1236313A Novel methods
11/24/1999CN1236299A Method of treating post menopausal diseases, including osteoporosis
11/23/1999US5990173 Anticholesterol agents; treating atherosclerosis; enzyme inhibitors of acylcoenzyme a:cholesterol acyltransferase (acat)
11/23/1999US5990129 Regulation of trka, the receptor for the neurotrophin nerve growth factor (ngf), by the administration of 2-aryl-3-aroylbenzo(b)thiophenes of given formula
11/23/1999US5989578 Associations of active principles containing clopidogrel and an antithrombotic agent
11/18/1999WO1999058524A1 Benzocarbazole and indenoindole derived estrogenic agents
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058501A1 Compounds with growth hormone releasing properties
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 290